Marshfield Associates Grows Position in UnitedHealth Group Incorporated $UNH

Marshfield Associates increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 58.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,613,248 shares of the healthcare conglomerate’s stock after acquiring an additional 594,960 shares during the quarter. UnitedHealth Group comprises 9.6% of Marshfield Associates’ holdings, making the stock its 3rd biggest position. Marshfield Associates owned 0.18% of UnitedHealth Group worth $557,055,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Sagard Holdings Management Inc. acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $29,000. Foster Dykema Cabot & Partners LLC increased its stake in UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 34 shares in the last quarter. 1248 Management LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $29,000. Hurley Capital LLC raised its stake in UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 40 shares during the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $285.55 on Tuesday. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The stock has a 50-day moving average of $302.22 and a 200 day moving average of $325.14. The stock has a market capitalization of $259.19 billion, a price-to-earnings ratio of 21.65, a PEG ratio of 1.30 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the company posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group’s payout ratio is currently 67.02%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on UNH shares. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Piper Sandler reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Weiss Ratings lowered UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. Finally, Royal Bank Of Canada decreased their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $372.13.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analyst bullish case: A Seeking Alpha piece argues UNH is a buy, citing attractive valuation, management’s focus on efficiency, and targeted AI-driven cost savings (~$1B) plus 2026 guidance (EPS > $17.75, revenue ~ $439B) that support a turnaround thesis. UnitedHealth: Why AI Is The Secret Weapon For The Turnaround
• Positive Sentiment: Product expansion: UnitedHealthcare expanded its doula support nationwide for employer plans — a growth/benefit initiative that can improve maternal outcomes and strengthen commercial plan stickiness. This is a near-term product win that supports revenue diversification and member engagement. UnitedHealthcare Expands Doula Offering to Employer-Sponsored Plans Nationwide
• Neutral Sentiment: Bull summaries / investor letters: Two market writeups reiterate a bullish long-term view based on valuation and earnings power, arguing current multiples present a buying opportunity for longer-term investors — useful context but not new company-level catalysts. Is UnitedHealth Group Incorporated (UNH) A Good Stock To Buy Now? Is UnitedHealth Group Incorporated (UNH) A Good Stock To Buy Now?
• Neutral Sentiment: Leadership and margin-repair narrative: Appointing Dennis Stankiewicz as Chief Accounting Officer and conference presentations signal governance and messaging steps as UNH works through 2025 headwinds; these are supportive but execution-dependent. How Leadership Shifts and Margin Repair Efforts At UnitedHealth Group (UNH) Has Changed Its Investment Story
• Negative Sentiment: Analyst caution / valuation: A Seeking Alpha Hold note says UNH is stabilizing but not yet a buy — revenue/membership declines reflect strategic resets and valuation compression removes prior premium, suggesting limited margin of safety for new capital. UnitedHealth: Stabilizing, But Not Yet A Buy
• Negative Sentiment: Policy/regulatory risk: A Joint Economic Committee analysis found ~$13.4B in 2025 excess Medicare Advantage payments (about $212 per enrollee), a headline that fuels regulatory scrutiny and could pressure margins or future reimbursement structures. Seniors Overpaid Medicare Premiums By $13.4B In 2025…

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.